What is Frank D. Lee’s Bausch Health (BHC) share ownership after this RSU grant?

After the reported RSU grant, Frank D. Lee directly holds 95,210 common shares. This total reflects his position following the award of 45,871 restricted share units described in the Form 4 filing.

Bausch Health director granted 45,871 RSUs worth $250K

Lee Frank D. reported acquisition or exercise transactions in this Form 4 filing.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Lee Frank D. reported acquisition or exercise transactions in this Form 4 filing.

Bausch Health Companies Inc. director Frank D. Lee received an equity grant in the form of restricted share units. On the grant date, he was awarded 45,871 RSUs with a grant date value of $250,000, at a per-share price of $0.00 as a non-cash compensation award.

The RSUs were granted to non-employee directors on the third business day following their election at the Annual Meeting of Shareholders. They vest on the date immediately preceding the next Annual Meeting of Shareholders and will be settled in common shares. Following this grant, Lee directly owns 95,210 common shares.

Insider Trade Summary

Grant/Award: 45,871 shares

Grant/Award 1 txn

Insider Lee Frank D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares, No Par Value	45,871	$0.00	$0.00

Holdings After Transaction: Common Shares, No Par Value — 95,210 shares (Direct)

Footnotes (1)

F1. Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Key Figures

RSUs granted: 45,871 units Grant date value: $250,000 Transaction price per share: $0.00/share +2 more

5 metrics

RSUs granted 45,871 units Award to non-employee director on third business day after election

Grant date value $250,000 Value of RSU award to non-employee director

Transaction price per share $0.00/share Indicates non-cash equity compensation grant

Shares owned after grant 95,210 shares Total common shares directly owned following RSU award

Vesting timing Immediately before next annual meeting RSUs vest before the next Annual Meeting of Shareholders

Key Terms

restricted share units ("RSUs"), Annual Meeting of Shareholders, grant date value

3 terms

Annual Meeting of Shareholders financial

"granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders"

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

grant date value financial

"The RSUs have a grant date value of $250,000, vest on the date immediately preceding"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Bausch Health (BHC) director Frank D. Lee report in this Form 4?

Director Frank D. Lee reported receiving 45,871 restricted share units as an equity grant. These RSUs are part of his compensation as a non-employee director and will be settled in Bausch Health common shares when they vest.

How large is the RSU award reported by Bausch Health (BHC) director Frank D. Lee?

The award consists of 45,871 restricted share units with a grant date value of $250,000. This is a stock-based compensation grant, not a cash payment or open-market purchase, and is settled in common shares when vesting conditions are met.

When do Frank D. Lee’s Bausch Health (BHC) RSUs vest and settle?

The RSUs vest on the date immediately preceding Bausch Health’s next Annual Meeting of Shareholders. Once vested, they are settled in common shares with no par value, according to the terms described in the Form 4 footnote.

Did Bausch Health (BHC) director Frank D. Lee buy or sell shares on the market?

The Form 4 shows a grant of restricted share units coded as an acquisition award, not an open-market buy or sell. The transaction price per share is listed as $0.00, indicating a compensation-related equity grant rather than a market transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/26/2026 - 06:25 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lee Frank D.

(Last)

(First)

(Middle)

400 SOMERSET CORPORATE BLVD.

(Street)

BRIDGEWATER

NEW JERSEY

08807

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares, No Par Value	05/22/2026		A		45,871⁽¹⁾	A	$0	95,210	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

	/s/ Brianna M. Dorsi, attorney-in-fact	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR